What is NDC 50228-111?

50228-111 is the product NDC for Hydrochlorothiazide, Hydrochlorothiazide 25 mg/1 tablet, listed with the FDA by ScieGen Pharmaceuticals, Inc.. It has 2 package NDCs, shown above in 10- and 11-digit form.

ScieGen Pharmaceuticals, Inc., NDC labeler code 50228. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Hydrochlorothiazide?

167 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Hydrochlorothiazide NDC 50228-111 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)50228-111Labeler and product segments. Claims need a package NDC.

Product NDC at billing width50228-0111Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
50228-111-10	50228011110	1000 TABLET in 1 BOTTLE (50228-111-10)Marketed from Jul 23, 2014
50228-111-30	50228011130	30 TABLET in 1 BOTTLE (50228-111-30)Marketed from Jul 23, 2014

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Hydrochlorothiazide
Generic name (nonproprietary): hydrochlorothiazide
Active ingredients: Hydrochlorothiazide — 25 mg/1
Dosage form: Tablet
Route: Oral
Labeler: ScieGen Pharmaceuticals, Inc.NDC labeler code 50228
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 203018
Marketing start: Jul 23, 2014
Listing expires: Dec 31, 2026
Other FDA classes: Increased Diuresis (Physiologic effect)Thiazides (Chemical structure)
Identifiers: Product ID 50228-111_5c6f4c6a-cc43-4f4d-bc16-688310c98c72SPL ID 5c6f4c6a-cc43-4f4d-bc16-688310c98c72SPL set ID 02e96a51-1d56-460c-8c20-3d6f37e0ce46RxCUI 197770, 310798UNII 0J48LPH2THUPC 0350228111300, 0350228111102, 0350228112109
Pharmacologic class: Thiazide Diuretic

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N450228011110 followed by a unit qualifier and the quantity

Package 50228-0111-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective May 11, 2020.

Indications (excerpt from the label)

INDICATIONS AND USAGE: Hydrochlorothiazide tablets are indicated as adjunctive therapy in edema associated with congestive heart failure, hepatic cirrhosis, and corticosteroid and estrogen therapy. Hydrochlorothiazide tablets have also been found useful in edema due to various forms of renal dysfunction such as nephrotic syndrome, acute glomerulonephritis, and chronic renal failure. Hydrochlorothiazide tablets are indicated in the management of hypertension either as the sole therapeutic agent or to enhance the effectiveness of other antihypertensive drugs in the more severe forms of hypertension. Use in Pregnancy Routine use of diuretics during normal pregnancy is inappropriate and exposes …

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 50228-111

What is NDC 50228-111?: 50228-111 is the product NDC for Hydrochlorothiazide, Hydrochlorothiazide 25 mg/1 tablet, listed with the FDA by ScieGen Pharmaceuticals, Inc.. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Hydrochlorothiazide.
What is the active ingredient?: Hydrochlorothiazide.
Who is the labeler?: ScieGen Pharmaceuticals, Inc., NDC labeler code 50228. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Hydrochlorothiazide?: 167 other product NDCs are listed under this name. See all Hydrochlorothiazide NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Hydrochlorothiazide NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
hydrochlorothiazide	Hydrochlorothiazide 12.5 mg/1	CapsuleOral	Preferred Pharmaceuticals Inc.	68788-4192	68788-4192-0168788-4192-0368788-4192-06+2 more
Hydrochlorothiazide	Hydrochlorothiazide 12.5 mg/1	TabletOral	REMEDYREPACK INC.	70518-4736	70518-4736-00
Hydrochlorothiazide	Hydrochlorothiazide 25 mg/1	TabletOral	Unit Dose Solutions, Inc.	87441-038	87441-0038-01
Hydrochlorothiazide	Hydrochlorothiazide 12.5 mg/1	TabletOral	Coupler LLC	67046-1664	67046-1664-03
Hydrochlorothiazide	Hydrochlorothiazide 25 mg/1	TabletOral	American Health Packaging	60687-894	60687-0894-01
Hydrochlorothiazide	Hydrochlorothiazide 50 mg/1	TabletOral	REMEDYREPACK INC.	70518-4525	70518-4525-00
Hydrochlorothiazide	Hydrochlorothiazide 12.5 mg/1	TabletOral	REMEDYREPACK INC.	70518-4466	70518-4466-0070518-4466-01
Hydrochlorothiazide	Hydrochlorothiazide 25 mg/1	TabletOral	REMEDYREPACK INC.	70518-4359	70518-4359-0070518-4359-0170518-4359-02+1 more
Hydrochlorothiazide	Hydrochlorothiazide 12.5 mg/1	TabletOral	Teva Pharmaceuticals USA, Inc.	0172-3444	00172-3444-6000172-3444-80
Hydrochlorothiazide	Hydrochlorothiazide 12.5 mg/1	TabletOral	A-S Medication Solutions	50090-7772	50090-7772-0050090-7772-0250090-7772-03

All 168 Hydrochlorothiazide NDCs

Other NDCs under ANDA 203018

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 203018
Product	Strength	Form · route	Labeler	Product NDC
Hydrochlorothiazide	Hydrochlorothiazide 50 mg/1	TabletOral	ScieGen Pharmaceuticals, Inc.	50228-112